INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Durata Therapeutics Inc. Regarding the...
October 06 2014 - 6:43PM
Business Wire
The Law Offices of Vincent Wong are investigating potential
claims against the Board of Directors of Durata Therapeutics Inc.
(Nasdaq:DRTX) (“Durata”) in connection with the sale of the Company
to Actavis (NYSE: ACT).
Click here to learn about the case:
http://docs.wongesq.com/DRTX-Info-Request-Form-431. There is
no cost or obligation to you.
Under the terms of the transaction, Durata shareholders will
receive $23.00 in cash for each share of Durata common stock they
own, as well as contingent value rights entitling the holder to
additional cash payments of up to $5.00 per share upon the
achievement of particular milestones. The investigation concerns
whether the Board of Durata breached their fiduciary duty to
stockholders by failing to adequately shop the Company before
agreeing to enter into this transaction, and whether Actavis is
underpaying for Durata shares.
If you own common stock in Durata and wish to obtain additional
information, please contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://docs.wongesq.com/DRTX-Info-Request-Form-431.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
The Law Offices of Vincent WongVincent Wong, Esq.,
212-425-1140Fax. 866-699-3880vw@wongesq.com
(MM) (NASDAQ:DRTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:DRTX)
Historical Stock Chart
From Jul 2023 to Jul 2024